Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in ...

His first case: the mysterious closure of Yadu’s Pav Bhaji, followed by an epic farm adventure with Swapna Di. In the ...

(Bloomberg) -- Merck KGaA posted earnings that topped estimates as its life science unit recovers from its post-pandemic ...

The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...

Merck KGaA on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by temporarily lower spending on drug ...

In a report released on November 14, David Evans from Kepler Capital maintained a Buy rating on Merck KGaA (0O14 – Research Report), ...

Investing.com -- Shares of Merck KGaA (ETR: MRCG) fell over 4% on Thursday following a mixed reception to its third-quarter ...

DUBLIN--(BUSINESS WIRE)--The "European Life Science Tools and Reagents Market" report has been added to ResearchAndMarkets.com's offering. The European market for life science tools and reagents and ...

Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor ...

Merck KGaA (MKGAF) reports robust performance with 4% organic growth and confirms 2024 targets despite currency challenges.

Merck, which previously predicted 2024 sales of between ... data analyses and commentary from our global network of life ...

Merck & Co has entered into an exclusive global license to develop, manufacture and commercialize LM-299 from China-based ...